Analysis of GNA13 Protein in Follicular Lymphoma and its Association with Poor Prognosis

Joji Shimono, Hiroaki Miyoshi, Noriaki Yoshida, Takeharu Kato, Kensaku Sato, Takeshi Sugio, Kohta Miyawaki, Daisuke Kurita, Yuya Sasaki, Keisuke Kawamoto, Yoshitaka Imaizumi, Koji Kato, Koji Nagafuji, Koichi Akashi, Masao Seto, Takanori Teshima, Koichi Ohshima

研究成果: ジャーナルへの寄稿記事

抄録

GNA13 is a G protein involved in modulating tumor proliferative capacity, infiltration, metastasis, and migration. Genomic alteration of GNA13 was frequently observed in follicular lymphoma (FL). In this study, we examined 167 cases of FL by immunostaining of GNA13 using tissue microarray to evaluate the clinical significance. There were 26 GNA13-positive cases (15.6%) and 141 GNA13-negative cases (84.4%). GNA13-positive cases had a higher incidence of early progression of disease for which disease progression was recognized within 2 years compared with GNA13-negative cases (P=0.03). There were no significant differences in other clinicopathologic factors including histological grade, BCL2-IGH translocation, immunohistochemical phenotype, and Follicular Lymphoma International Prognostic Index. In addition, overall survival and progression-free survival were poorer in GNA13-positive cases than in GNA13-negative cases (P=0.009 and 0.005, respectively). In multivariate analysis, GNA13 positivity was found to be a poor prognostic factor for overall survival and progression-free survival. Thus, GNA13 protein expression was an independent prognostic factor and may affect disease progression in FL.

元の言語英語
ページ(範囲)1466-1471
ページ数6
ジャーナルAmerican Journal of Surgical Pathology
42
発行部数11
DOI
出版物ステータス出版済み - 11 1 2018

Fingerprint

Follicular Lymphoma
Disease Progression
Disease-Free Survival
Proteins
GTP-Binding Proteins
Multivariate Analysis
Neoplasm Metastasis
Phenotype
Incidence
Neoplasms

All Science Journal Classification (ASJC) codes

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

これを引用

Shimono, J., Miyoshi, H., Yoshida, N., Kato, T., Sato, K., Sugio, T., ... Ohshima, K. (2018). Analysis of GNA13 Protein in Follicular Lymphoma and its Association with Poor Prognosis. American Journal of Surgical Pathology, 42(11), 1466-1471. https://doi.org/10.1097/PAS.0000000000000969

Analysis of GNA13 Protein in Follicular Lymphoma and its Association with Poor Prognosis. / Shimono, Joji; Miyoshi, Hiroaki; Yoshida, Noriaki; Kato, Takeharu; Sato, Kensaku; Sugio, Takeshi; Miyawaki, Kohta; Kurita, Daisuke; Sasaki, Yuya; Kawamoto, Keisuke; Imaizumi, Yoshitaka; Kato, Koji; Nagafuji, Koji; Akashi, Koichi; Seto, Masao; Teshima, Takanori; Ohshima, Koichi.

:: American Journal of Surgical Pathology, 巻 42, 番号 11, 01.11.2018, p. 1466-1471.

研究成果: ジャーナルへの寄稿記事

Shimono, J, Miyoshi, H, Yoshida, N, Kato, T, Sato, K, Sugio, T, Miyawaki, K, Kurita, D, Sasaki, Y, Kawamoto, K, Imaizumi, Y, Kato, K, Nagafuji, K, Akashi, K, Seto, M, Teshima, T & Ohshima, K 2018, 'Analysis of GNA13 Protein in Follicular Lymphoma and its Association with Poor Prognosis', American Journal of Surgical Pathology, 巻. 42, 番号 11, pp. 1466-1471. https://doi.org/10.1097/PAS.0000000000000969
Shimono, Joji ; Miyoshi, Hiroaki ; Yoshida, Noriaki ; Kato, Takeharu ; Sato, Kensaku ; Sugio, Takeshi ; Miyawaki, Kohta ; Kurita, Daisuke ; Sasaki, Yuya ; Kawamoto, Keisuke ; Imaizumi, Yoshitaka ; Kato, Koji ; Nagafuji, Koji ; Akashi, Koichi ; Seto, Masao ; Teshima, Takanori ; Ohshima, Koichi. / Analysis of GNA13 Protein in Follicular Lymphoma and its Association with Poor Prognosis. :: American Journal of Surgical Pathology. 2018 ; 巻 42, 番号 11. pp. 1466-1471.
@article{617ea544467d4210b7eb06bfb5afb915,
title = "Analysis of GNA13 Protein in Follicular Lymphoma and its Association with Poor Prognosis",
abstract = "GNA13 is a G protein involved in modulating tumor proliferative capacity, infiltration, metastasis, and migration. Genomic alteration of GNA13 was frequently observed in follicular lymphoma (FL). In this study, we examined 167 cases of FL by immunostaining of GNA13 using tissue microarray to evaluate the clinical significance. There were 26 GNA13-positive cases (15.6{\%}) and 141 GNA13-negative cases (84.4{\%}). GNA13-positive cases had a higher incidence of early progression of disease for which disease progression was recognized within 2 years compared with GNA13-negative cases (P=0.03). There were no significant differences in other clinicopathologic factors including histological grade, BCL2-IGH translocation, immunohistochemical phenotype, and Follicular Lymphoma International Prognostic Index. In addition, overall survival and progression-free survival were poorer in GNA13-positive cases than in GNA13-negative cases (P=0.009 and 0.005, respectively). In multivariate analysis, GNA13 positivity was found to be a poor prognostic factor for overall survival and progression-free survival. Thus, GNA13 protein expression was an independent prognostic factor and may affect disease progression in FL.",
author = "Joji Shimono and Hiroaki Miyoshi and Noriaki Yoshida and Takeharu Kato and Kensaku Sato and Takeshi Sugio and Kohta Miyawaki and Daisuke Kurita and Yuya Sasaki and Keisuke Kawamoto and Yoshitaka Imaizumi and Koji Kato and Koji Nagafuji and Koichi Akashi and Masao Seto and Takanori Teshima and Koichi Ohshima",
year = "2018",
month = "11",
day = "1",
doi = "10.1097/PAS.0000000000000969",
language = "English",
volume = "42",
pages = "1466--1471",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Analysis of GNA13 Protein in Follicular Lymphoma and its Association with Poor Prognosis

AU - Shimono, Joji

AU - Miyoshi, Hiroaki

AU - Yoshida, Noriaki

AU - Kato, Takeharu

AU - Sato, Kensaku

AU - Sugio, Takeshi

AU - Miyawaki, Kohta

AU - Kurita, Daisuke

AU - Sasaki, Yuya

AU - Kawamoto, Keisuke

AU - Imaizumi, Yoshitaka

AU - Kato, Koji

AU - Nagafuji, Koji

AU - Akashi, Koichi

AU - Seto, Masao

AU - Teshima, Takanori

AU - Ohshima, Koichi

PY - 2018/11/1

Y1 - 2018/11/1

N2 - GNA13 is a G protein involved in modulating tumor proliferative capacity, infiltration, metastasis, and migration. Genomic alteration of GNA13 was frequently observed in follicular lymphoma (FL). In this study, we examined 167 cases of FL by immunostaining of GNA13 using tissue microarray to evaluate the clinical significance. There were 26 GNA13-positive cases (15.6%) and 141 GNA13-negative cases (84.4%). GNA13-positive cases had a higher incidence of early progression of disease for which disease progression was recognized within 2 years compared with GNA13-negative cases (P=0.03). There were no significant differences in other clinicopathologic factors including histological grade, BCL2-IGH translocation, immunohistochemical phenotype, and Follicular Lymphoma International Prognostic Index. In addition, overall survival and progression-free survival were poorer in GNA13-positive cases than in GNA13-negative cases (P=0.009 and 0.005, respectively). In multivariate analysis, GNA13 positivity was found to be a poor prognostic factor for overall survival and progression-free survival. Thus, GNA13 protein expression was an independent prognostic factor and may affect disease progression in FL.

AB - GNA13 is a G protein involved in modulating tumor proliferative capacity, infiltration, metastasis, and migration. Genomic alteration of GNA13 was frequently observed in follicular lymphoma (FL). In this study, we examined 167 cases of FL by immunostaining of GNA13 using tissue microarray to evaluate the clinical significance. There were 26 GNA13-positive cases (15.6%) and 141 GNA13-negative cases (84.4%). GNA13-positive cases had a higher incidence of early progression of disease for which disease progression was recognized within 2 years compared with GNA13-negative cases (P=0.03). There were no significant differences in other clinicopathologic factors including histological grade, BCL2-IGH translocation, immunohistochemical phenotype, and Follicular Lymphoma International Prognostic Index. In addition, overall survival and progression-free survival were poorer in GNA13-positive cases than in GNA13-negative cases (P=0.009 and 0.005, respectively). In multivariate analysis, GNA13 positivity was found to be a poor prognostic factor for overall survival and progression-free survival. Thus, GNA13 protein expression was an independent prognostic factor and may affect disease progression in FL.

UR - http://www.scopus.com/inward/record.url?scp=85054774613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054774613&partnerID=8YFLogxK

U2 - 10.1097/PAS.0000000000000969

DO - 10.1097/PAS.0000000000000969

M3 - Article

C2 - 30307409

AN - SCOPUS:85054774613

VL - 42

SP - 1466

EP - 1471

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 11

ER -